176 related articles for article (PubMed ID: 36581010)
1. Concurrent participation in breast, cervical, and colorectal cancer screening programmes in Denmark: A nationwide registry-based study.
Njor SH; Søborg B; Tranberg M; Rebolj M
Prev Med; 2023 Feb; 167():107405. PubMed ID: 36581010
[TBL] [Abstract][Full Text] [Related]
2. Concurrent participation in breast, cervical, and colorectal cancer screening in the Netherlands.
Kregting LM; Olthof EMG; Breekveldt ECH; Aitken CA; Heijnsdijk EAM; Toes-Zoutendijk E; de Koning HJ; van Ravesteyn NT
Eur J Cancer; 2022 Nov; 175():180-186. PubMed ID: 36126478
[TBL] [Abstract][Full Text] [Related]
3. Breast, Cervical, and Colorectal Cancer Screening Adherence: Effect of Low Body Mass Index in Women.
Charkhchi P; Schabath MB; Carlos RC
J Womens Health (Larchmt); 2020 Jul; 29(7):996-1006. PubMed ID: 31928405
[No Abstract] [Full Text] [Related]
4. Methods to increase participation in organised screening programs: a systematic review.
Camilloni L; Ferroni E; Cendales BJ; Pezzarossi A; Furnari G; Borgia P; Guasticchi G; Giorgi Rossi P;
BMC Public Health; 2013 May; 13():464. PubMed ID: 23663511
[TBL] [Abstract][Full Text] [Related]
5. Breast, Cervical, and Colorectal Cancer Screening: Patterns Among Women With Medicaid and Commercial Insurance.
Bonafede MM; Miller JD; Pohlman SK; Troeger KA; Sprague BL; Herschorn SD; Winer IH
Am J Prev Med; 2019 Sep; 57(3):394-402. PubMed ID: 31377088
[TBL] [Abstract][Full Text] [Related]
6. Predictive factors for non-participation or partial participation in breast, cervical and colorectal cancer screening programmes†.
Dawidowicz S; Le Breton J; Moscova L; Renard V; Bercier S; Brixi Z; Audureau E; Clerc P; Bastuji-Garin S; Ferrat E
Fam Pract; 2020 Feb; 37(1):15-24. PubMed ID: 31305884
[TBL] [Abstract][Full Text] [Related]
7. Comparing barriers to colorectal cancer screening with barriers to breast and cervical screening: a population-based survey of screening-age women in Great Britain.
Lo SH; Waller J; Wardle J; von Wagner C
J Med Screen; 2013 Jun; 20(2):73-9. PubMed ID: 23761420
[TBL] [Abstract][Full Text] [Related]
8. Concurrent participation in screening for cervical, breast, and bowel cancer in England.
Rebolj M; Parmar D; Maroni R; Blyuss O; Duffy SW
J Med Screen; 2020 Mar; 27(1):9-17. PubMed ID: 31525303
[TBL] [Abstract][Full Text] [Related]
9. Effect of Time to Diagnostic Testing for Breast, Cervical, and Colorectal Cancer Screening Abnormalities on Screening Efficacy: A Modeling Study.
Rutter CM; Kim JJ; Meester RGS; Sprague BL; Burger EA; Zauber AG; Ergun MA; Campos NG; Doubeni CA; Trentham-Dietz A; Sy S; Alagoz O; Stout N; Lansdorp-Vogelaar I; Corley DA; Tosteson ANA
Cancer Epidemiol Biomarkers Prev; 2018 Feb; 27(2):158-164. PubMed ID: 29150480
[No Abstract] [Full Text] [Related]
10. Influence of health insurance coverage on breast, cervical, and colorectal cancer screening in rural primary care settings.
Carney PA; O'Malley J; Buckley DI; Mori M; Lieberman DA; Fagnan LJ; Wallace J; Liu B; Morris C
Cancer; 2012 Dec; 118(24):6217-25. PubMed ID: 22648383
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with non-participation in cervical cancer screening - A nationwide study of nearly half a million women in Denmark.
Harder E; Juul KE; Jensen SM; Thomsen LT; Frederiksen K; Kjaer SK
Prev Med; 2018 Jun; 111():94-100. PubMed ID: 29501474
[TBL] [Abstract][Full Text] [Related]
12. Comparing uptake across breast, cervical and bowel screening at an individual level: a retrospective cohort study.
McCowan C; McSkimming P; Papworth R; Kotzur M; McConnachie A; Macdonald S; Wyke S; Crighton E; Campbell C; Weller D; Steele RJC; Robb KA
Br J Cancer; 2019 Oct; 121(8):710-714. PubMed ID: 31481732
[TBL] [Abstract][Full Text] [Related]
13. The impact of COVID-19 on screening for colorectal, gastric, breast, and cervical cancer in Korea.
Park H; Seo SH; Park JH; Yoo SH; Keam B; Shin A
Epidemiol Health; 2022; 44():e2022053. PubMed ID: 35760396
[TBL] [Abstract][Full Text] [Related]
14. Invitation coverage and participation in Italian cervical, breast and colorectal cancer screening programmes.
Giorgi Rossi P; Carrozzi G; Federici A; Mancuso P; Sampaolo L; Zappa M
J Med Screen; 2018 Mar; 25(1):17-23. PubMed ID: 28614991
[TBL] [Abstract][Full Text] [Related]
15. Increasing breast, cervical, and colorectal cancer screening among rural women: Baseline characteristics of a randomized control trial.
Biederman E; Baltic R; Katz ML; Rawl S; Vachon E; Monahan PO; Stump TE; Kettler C; Carter L; Young G; Xu W; Paskett ED; Champion V
Contemp Clin Trials; 2022 Dec; 123():106986. PubMed ID: 36328234
[TBL] [Abstract][Full Text] [Related]
16. "It's cancer screening after all". Barriers to cervical and colorectal cancer screening and attitudes to promotion of self-sampling kits upon attendance for breast cancer screening.
Kirkegaard P; Larsen MB; Andersen B
J Med Screen; 2023 Jun; 30(2):74-80. PubMed ID: 36541340
[TBL] [Abstract][Full Text] [Related]
17. Temporal trend in socioeconomic inequalities in the uptake of cancer screening programmes in France between 2005 and 2010: results from the Cancer Barometer surveys.
Kelly DM; Estaquio C; Léon C; Arwidson P; Nabi H
BMJ Open; 2017 Dec; 7(12):e016941. PubMed ID: 29247085
[TBL] [Abstract][Full Text] [Related]
18. Participation in cervical cancer screening among immigrants and Danish-born women in Denmark.
Hertzum-Larsen R; Kjær SK; Frederiksen K; Thomsen LT
Prev Med; 2019 Jun; 123():55-64. PubMed ID: 30796926
[TBL] [Abstract][Full Text] [Related]
19. How do women comply with cancer screenings? A study in four regions of France.
Duchange N; Poiseuil M; Rollet Q; Piette C; Cosson M; Quertier MC; Moutel G; Darquy S
BMC Womens Health; 2023 Apr; 23(1):190. PubMed ID: 37085818
[TBL] [Abstract][Full Text] [Related]
20. A population-based survey of self-reported delays in breast, cervical, colorectal and lung cancer screening.
Gunn CM; Berrian K; Weiss JE; Tosteson AAN; Hasson RM; Di Florio-Alexander R; Peacock JL; Rees JR
Prev Med; 2023 Oct; 175():107649. PubMed ID: 37517458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
